rxstat › Classes › Dopaminergic Agents

Dopaminergic Agents: shortage status in Canada

6 of the 7 dopaminergic agents rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Bromocriptine Partial shortage 1 of 2 reported products affected · est. return Nov 13, 2026 Carbidopa Levodopa (Sinemet) Partial shortage 4 of 21 reported products affected · est. return Nov 30, 2026 Entacapone (Comtan) Partial shortage 1 of 5 reported products affected · est. return Jan 31, 2027 Rasagiline (Azilect) Partial shortage 2 of 7 reported products affected · est. return Nov 27, 2026 Ropinirole (Requip) Partial shortage 3 of 23 reported products affected Selegiline Partial shortage 1 of 3 reported products affected Pramipexole Dihydrochloride (Mirapex) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.